Evidence map›Paper›PMID 42183773›Full record

ArticleActa dermato-venereologica2026

From Onset to Outcome: A Long-term Retrospective, Single centre Study of Guttate Psoriasis from Israel.

Riad Kassem, Nofar Edri, Aviv Barzilai, Eran Galili, Anna Lyakhovitsky, Ido Tzanani, Assaf Handelsman, Sharon Baum, Felix Pavlotsky

Abstract read
In one paragraph

Article in Acta dermato-venereologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Riad KassemGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel; Dermatology Department, Sheba Medical Center, Tel HaShomer, Ramat Gan 52621, Israel. riadkassem@hotmail.com.ORCID 0000-0003-2964-7417
Nofar EdriGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel.
Aviv BarzilaiGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel; Dermatology Department, Sheba Medical Center, Tel HaShomer, Ramat Gan 52621, Israel; Dermatology Department, Sourasky Medical Center, Tel Aviv, 6423906, Israel.
Eran GaliliGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel; Dermatology Department, Sheba Medical Center, Tel HaShomer, Ramat Gan 52621, Israel.
Anna LyakhovitskyGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel; Dermatology Department, Sheba Medical Center, Tel HaShomer, Ramat Gan 52621, Israel.
Ido TzananiGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel; Dermatology Department, Sheba Medical Center, Tel HaShomer, Ramat Gan 52621, Israel.
Assaf HandelsmanGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel; Dermatology Department, Sourasky Medical Center, Tel Aviv, 6423906, Israel.
Sharon BaumGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel; Dermatology Department, Sheba Medical Center, Tel HaShomer, Ramat Gan 52621, Israel.
Felix PavlotskyGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, 69978, Israel; Dermatology Department, Sheba Medical Center, Tel HaShomer, Ramat Gan 52621, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guttate psoriasis is often precipitated by strepto-coccal infections and is generally regarded as a mild subtype of psoriasis; however, its potential associations with systemic comorbidities are insufficiently explored. In this study, we aimed to evaluate the association of guttate psoriasis with systemic comorbidities such as metabolic syndrome and psoriatic arthritis and identify factors affecting recurrence. In this retrospective single-centercentre study, we reviewed the data of patients with the first eruption of guttate psoriasis between 1998 and 2020 and at least 4 years of follow-up data. Demographic information and medical data (type of treatment, psoriasis flare-ups, remission of disease, and development of metabolic syndrome and/or psoriatic arthritis) were retrieved. Of 395 patients included (mean follow up, 83±34.7 months), 34.9 % experienced at least one recurrence, 14.68 % had multiple recurrences, 5.6 % developed psoriatic arthritis, and 8.6 % had metabolic syndrome. Male sex, topical treatment and residual disease were significant risk factors for recurrence. Psoriatic arthritis was strongly associated with multiple recurrences, while a possible association with metabolic syndrome was observed, highlighting the importance of careful long-term monitoring in this population.

Indexed as

Guttate PsoriasisMetabolic SyndromeAdultAgedArthritis, PsoriaticComorbidityFemaleHumansIsraelMaleMiddle AgedRecurrenceRetrospective StudiesRisk FactorsTime FactorsTreatment Outcome

Identifiers

PMID42183773
PMCPMC13200514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.